CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators-Reference-Cited by-同舟云学术

CB1 receptor binding sites for NAM and PAM: A first approach for studying, new n‑butyl‑diphenylcarboxamides as allosteric modulators

Published:2022-02 Issue: Volume:169 Page:106088
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Gado Francesca,Ceni Costanza,Ferrisi Rebecca,Sbrana Giulia,Stevenson Lesley A.,Macchia Marco,Pertwee Roger G.,Bertini Simone,Manera Clementina,Ortore Gabriella

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference40 articles.

1. An introduction to the endogenous cannabinoid system;Lu;Biol. Psychiatry,2016

2. Distribution of the endocannabinoid system in the central nervous system. In Endocannabinoids;Hu,2015

3. International union of basic and clinical pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB1 and CB2;Pertwee;Pharmacol Rev,2010

4. Role of cannabinoid receptor type 1 in insulin resistance and its biological implications;Nagappan;IJMS,2019

5. CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction;Lipina;Aging Cell,2016

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. G protein-coupled receptors (GPCRs): advances in structures, mechanisms and drug discovery;Signal Transduction and Targeted Therapy;2024-04-10

2. Targeting the endocannabinoid system: Structural determinants and molecular mechanism of allosteric modulation;Drug Discovery Today;2023-07

3. Endocannabinoid-Binding Receptors as Drug Targets;Methods in Molecular Biology;2022-09-25